| NCT04460001 |
Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO) |
https://ClinicalTrials.gov/show/NCT04460001 |
Recruiting |
Assiut University |
2021-08-01 |
| NCT04457648 |
Manuka Honey Eye Drops VS Conventional Treatment of Meibomian Gland Dysfunction Related Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04457648 |
Completed |
Chinese University of Hong Kong |
2020-06-01 |
| NCT04393441 |
Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04393441 |
Recruiting |
Allergan |
2020-11-27 |
| NCT04387292 |
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic |
https://ClinicalTrials.gov/show/NCT04387292 |
Recruiting |
Fondation Ophtalmologique Adolphe de Rothschild |
2021-05-31 |
| NCT03333057 |
Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03333057 |
Completed |
Novaliq GmbH |
2018-05-18 |
| NCT03332342 |
Closed Eye Neutrophils in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03332342 |
Completed |
University of Alabama at Birmingham |
2018-12-12 |
| NCT03302273 |
Corneal Epithelial Stem Cells and Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03302273 |
Enrolling by invitation |
Panhandle Eye Group, LLP |
2021-02-01 |
| NCT03298867 |
Treatment of Graves’ Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study |
https://ClinicalTrials.gov/show/NCT03298867 |
Active, not recruiting |
Horizon Pharma USA, Inc. |
2019-02-13 |
| NCT03292809 |
CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03292809 |
Completed |
Novaliq GmbH |
2018-05-22 |
| NCT03287635 |
Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03287635 |
Recruiting |
Toyos Clinic |
2020-05-31 |
| NCT03278964 |
Analysis Between the Results of Two Surgical Techniques of Orbital Decompression in Patients With Graves Orbitopathy |
https://ClinicalTrials.gov/show/NCT03278964 |
Completed |
University of Sao Paulo General Hospital |
2019-01-31 |
| NCT03265652 |
IPL and MGX Versus MGX Alone in the Treatment of Dry Eye Disease Secondary to MGD |
https://ClinicalTrials.gov/show/NCT03265652 |
Completed |
Lumenis Ltd. |
2019-04-18 |
| NCT03216096 |
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03216096 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2018-02-01 |
| NCT03201588 |
Multi-Center Study to Determine the Role of Fatty Acids in Serum in Preventing Retinopathy of Prematurity (MDM) |
https://ClinicalTrials.gov/show/NCT03201588 |
Completed |
Göteborg University |
2019-11-15 |
| NCT03148132 |
VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP |
https://ClinicalTrials.gov/show/NCT03148132 |
Completed |
Universidad Autonoma de San Luis Potosà |
2018-08-30 |
| NCT03131726 |
Treatment of Graves´Ophthalmopathy With Simvastatin (GO-DS) |
https://ClinicalTrials.gov/show/NCT03131726 |
Recruiting |
Lund University |
2020-01-26 |
| NCT03127163 |
Intraestromal Corneal Ring in Mild Keratoconus |
https://ClinicalTrials.gov/show/NCT03127163 |
Completed |
University of Sao Paulo |
2016-01-10 |
| NCT03108664 |
HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03108664 |
Completed |
Sylentis, S.A. |
2018-10-16 |
| NCT03107078 |
Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial |
https://ClinicalTrials.gov/show/NCT03107078 |
Recruiting |
The Third Affiliated Hospital of Southern Medical University |
2019-10-01 |
| NCT03080714 |
Triton Agreement and Precision Study |
https://ClinicalTrials.gov/show/NCT03080714 |
Completed |
Topcon Medical Systems, Inc. |
2017-08-30 |
| NCT03052140 |
Lamelleye vs Comparator for the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03052140 |
Completed |
Glasgow Caledonian University |
2017-08-09 |
| NCT03048526 |
Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03048526 |
Completed |
Novaliq GmbH |
2017-04-18 |
| NCT02980224 |
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02980224 |
Completed |
OmegaD LLC |
2017-02-28 |
| NCT02967614 |
KJ-TFC-004 Drug-drug Interaction Study |
https://ClinicalTrials.gov/show/NCT02967614 |
Completed |
Kukje Pharma |
2017-12-31 |
| NCT02848222 |
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers |
https://ClinicalTrials.gov/show/NCT02848222 |
Completed |
University of Alabama at Birmingham |
2017-12-31 |
| NCT02845336 |
Celecoxib for Thyroid Eye Disease |
https://ClinicalTrials.gov/show/NCT02845336 |
Recruiting |
Johns Hopkins University |
2020-07-31 |
| NCT02823600 |
Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers |
https://ClinicalTrials.gov/show/NCT02823600 |
Completed |
University of North Carolina, Chapel Hill |
2017-05-31 |
| NCT02819284 |
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02819284 |
Completed |
Kala Pharmaceuticals, Inc. |
2017-09-30 |
| NCT02813265 |
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02813265 |
Completed |
Kala Pharmaceuticals, Inc. |
2017-10-31 |
| NCT02764814 |
In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye |
https://ClinicalTrials.gov/show/NCT02764814 |
Completed |
Tissue Tech Inc. |
2016-09-30 |
| NCT02710916 |
SD-OCT Multimodal Analysis in GLaucoma |
https://ClinicalTrials.gov/show/NCT02710916 |
Completed |
University Hospital, Bordeaux |
2018-12-21 |
| NCT02693808 |
New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression |
https://ClinicalTrials.gov/show/NCT02693808 |
Completed |
Haukeland University Hospital |
2018-01-31 |
| NCT02665234 |
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02665234 |
Completed |
Mimetogen Pharmaceuticals USA, Inc. |
2017-02-28 |
| NCT02617667 |
CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT02617667 |
Completed |
Novaliq GmbH |
2016-07-31 |
| NCT03404115 |
A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03404115 |
Completed |
Aldeyra Therapeutics, Inc. |
2018-07-11 |
| NCT02554084 |
Optical Coherence Tomography of Tear Film Dynamics In-Vivo |
https://ClinicalTrials.gov/show/NCT02554084 |
Completed |
University of Rochester |
2017-09-30 |
| NCT02553772 |
A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease. |
https://ClinicalTrials.gov/show/NCT02553772 |
Completed |
Allergan |
2016-09-09 |
| NCT02543229 |
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentisâ„¢ in Patients With Wet AMD |
https://ClinicalTrials.gov/show/NCT02543229 |
Completed |
Opthea Limited |
2017-02-07 |
| NCT02535975 |
The Effects of Metformin in Patients With Mild Graves’ Ophthalmopathy |
https://ClinicalTrials.gov/show/NCT02535975 |
Recruiting |
Yonsei University |
2019-10-31 |
| NCT02459782 |
Ultrasound Guided Peribulbar Anaesthesia - A Novel Dual Quadrant Injection Technique |
https://ClinicalTrials.gov/show/NCT02459782 |
Completed |
Sunnybrook Health Sciences Centre |
2012-03-31 |
| NCT02417116 |
Tear Osmolarity Clinical Utility in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02417116 |
Completed |
Aston University |
2019-01-31 |
| NCT02393183 |
The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED) |
https://ClinicalTrials.gov/show/NCT02393183 |
Recruiting |
Iran University of Medical Sciences |
2022-06-15 |
| NCT02378298 |
Rituximab (RTX) Therapy in Patients With Active TAO |
https://ClinicalTrials.gov/show/NCT02378298 |
Recruiting |
Göteborg University |
2019-05-31 |
| NCT02365519 |
LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02365519 |
Completed |
Alcon Research |
2015-10-16 |
| NCT02359149 |
Intravitreal Injections by Nurses and Physicians Compared |
https://ClinicalTrials.gov/show/NCT02359149 |
Completed |
St. Olavs Hospital |
2017-03-31 |
| NCT02284516 |
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3) |
https://ClinicalTrials.gov/show/NCT02284516 |
Completed |
Shire |
2015-10-05 |
| NCT02260960 |
The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02260960 |
Completed |
Physician Recommended Nutriceuticals |
2015-03-31 |
| NCT02254265 |
Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca |
https://ClinicalTrials.gov/show/NCT02254265 |
Completed |
Sun Pharma Global FZE |
2015-05-31 |
| NCT02242032 |
Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02242032 |
Completed |
Parion Sciences |
2015-03-31 |
| NCT02229955 |
Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02229955 |
Completed |
Hanlim Pharm. Co., Ltd. |
2014-04-30 |
| NCT02188160 |
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02188160 |
Completed |
Kala Pharmaceuticals, Inc. |
2015-01-31 |
| NCT02157077 |
Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT02157077 |
Completed |
Centre Hospitalier Intercommunal Creteil |
2015-12-31 |
| NCT02155049 |
Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues |
https://ClinicalTrials.gov/show/NCT02155049 |
Completed |
Rabin Medical Center |
2017-05-31 |
| NCT02136940 |
Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02136940 |
Completed |
Amakem, NV |
2014-11-30 |
| NCT02120079 |
The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED |
https://ClinicalTrials.gov/show/NCT02120079 |
Completed |
Tufts Medical Center |
2017-04-30 |
| NCT02089009 |
Comparison of Non-mydriatic Camera Systems in a Female Health Hospital |
https://ClinicalTrials.gov/show/NCT02089009 |
Completed |
University Hospital Tuebingen |
2016-02-29 |
| NCT02059655 |
Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) |
https://ClinicalTrials.gov/show/NCT02059655 |
Completed |
Cardiff University |
2016-03-31 |
| NCT01297699 |
Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) |
https://ClinicalTrials.gov/show/NCT01297699 |
Completed |
Hospital Clinico Universitario de Santiago |
2015-10-31 |
| NCT01276223 |
Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT01276223 |
Completed |
Alcon Research |
2012-01-31 |
| NCT02051023 |
Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca) |
https://ClinicalTrials.gov/show/NCT02051023 |
Completed |
Instituto Universitario de OftalmobiologÃa Aplicada (Institute of Applied Ophthalmobiology) - IOBA |
2014-12-31 |
| NCT04005352 |
Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) |
https://ClinicalTrials.gov/show/NCT04005352 |
Recruiting |
Novartis |
2022-01-31 |
| NCT03785340 |
Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03785340 |
Completed |
Ocugen |
2019-02-28 |
| NCT02004067 |
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02004067 |
Completed |
Federal University of São Paulo |
2016-08-31 |
| NCT02001129 |
Improving Follow-Up Adherence in a Primary Eye Care Setting |
https://ClinicalTrials.gov/show/NCT02001129 |
Completed |
Wills Eye |
2014-02-28 |
| NCT01998802 |
Phase 3 Study of EBI-005 in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01998802 |
Completed |
Eleven Biotherapeutics |
2015-03-31 |
| NCT04426331 |
Vouchers to Increase Uptake of Already Free Eye Care |
https://ClinicalTrials.gov/show/NCT04426331 |
Completed |
Johns Hopkins University |
2019-01-01 |
| NCT01880463 |
Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL) |
https://ClinicalTrials.gov/show/NCT01880463 |
Active, not recruiting |
Brigham and Women’s Hospital |
2020-12-31 |
| NCT01868997 |
Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease |
https://ClinicalTrials.gov/show/NCT01868997 |
Completed |
Horizon Pharma USA, Inc. |
2016-03-31 |
| NCT01817582 |
Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease) |
https://ClinicalTrials.gov/show/NCT01817582 |
Completed |
Bausch & Lomb Incorporated |
2014-01-10 |
| NCT01798966 |
Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease |
https://ClinicalTrials.gov/show/NCT01798966 |
Completed |
Sensimed AG |
2013-06-30 |
| NCT01775540 |
Systane Ultra Versus Maxidex Versus Saline |
https://ClinicalTrials.gov/show/NCT01775540 |
Completed |
Icahn School of Medicine at Mount Sinai |
2012-10-31 |
| NCT01743729 |
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye |
https://ClinicalTrials.gov/show/NCT01743729 |
Completed |
Shire |
2013-10-01 |
| NCT01738243 |
Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease |
https://ClinicalTrials.gov/show/NCT01738243 |
Recruiting |
University of California, Los Angeles |
2021-03-31 |
| NCT01727973 |
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves’ Orbitopathy |
https://ClinicalTrials.gov/show/NCT01727973 |
Completed |
Sun Yat-sen University |
2013-11-30 |
| NCT01693315 |
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma |
https://ClinicalTrials.gov/show/NCT01693315 |
Completed |
Amakem, NV |
2013-07-31 |
| NCT04125134 |
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests |
https://ClinicalTrials.gov/show/NCT04125134 |
Recruiting |
Tufts Medical Center |
2020-05-31 |
| NCT01675570 |
A Study of RX-10045 in the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01675570 |
Completed |
C.T. Development America, Inc. |
2012-11-30 |
| NCT01664949 |
A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVEâ„¢ in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01664949 |
Completed |
Allergan |
2014-05-31 |
| NCT01650584 |
Evaluation of Ocular Comfort With ISTA Tears vs Systane |
https://ClinicalTrials.gov/show/NCT01650584 |
Completed |
Bausch & Lomb Incorporated |
2012-12-31 |
| NCT01648452 |
CNTF Implants for CNGB3 Achromatopsia |
https://ClinicalTrials.gov/show/NCT01648452 |
Completed |
National Institutes of Health Clinical Center (CC) |
2013-03-31 |
| NCT01636206 |
Safety Study of Lifitegrast to Treat Dry Eye |
https://ClinicalTrials.gov/show/NCT01636206 |
Completed |
Shire |
2014-03-03 |
| NCT01599273 |
Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections |
https://ClinicalTrials.gov/show/NCT01599273 |
Completed |
Yonsei University |
2014-08-31 |
| NCT01579539 |
The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy |
https://ClinicalTrials.gov/show/NCT01579539 |
Completed |
Medical University of Vienna |
2017-05-18 |
| NCT01562795 |
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01562795 |
Completed |
Wenzhou Medical University |
2012-06-30 |
| NCT01494805 |
Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01494805 |
Completed |
Lions Eye Institute, Perth, Western Australia |
2017-05-31 |
| NCT01468168 |
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT01468168 |
Completed |
Santen Inc. |
2012-11-30 |
| NCT01458600 |
Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study) |
https://ClinicalTrials.gov/show/NCT01458600 |
Completed |
Region Skane |
2016-02-29 |
| NCT01421498 |
Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1) |
https://ClinicalTrials.gov/show/NCT01421498 |
Completed |
Shire |
2012-04-28 |
| NCT01399515 |
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01399515 |
Completed |
Seoul National University Hospital |
2013-08-31 |
| NCT04425551 |
Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction |
https://ClinicalTrials.gov/show/NCT04425551 |
Active, not recruiting |
Naval Hospital, Athens |
2020-09-30 |
| NCT04362670 |
Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease. |
https://ClinicalTrials.gov/show/NCT04362670 |
Active, not recruiting |
Ocular Therapeutix, Inc. |
2020-11-30 |
| NCT04271709 |
Manhattan Vision Screening and Follow-Up Study |
https://ClinicalTrials.gov/show/NCT04271709 |
Recruiting |
Columbia University |
2024-09-30 |
| NCT04268069 |
Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye |
https://ClinicalTrials.gov/show/NCT04268069 |
Recruiting |
ORA, Inc. |
2020-07-31 |
| NCT04202562 |
Efficacy and Safety of ab Interno Trabeculectomy With the Kahook Dual Blade |
https://ClinicalTrials.gov/show/NCT04202562 |
Completed |
Hospital San Carlos, Madrid |
2017-11-29 |
| NCT04201574 |
Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04201574 |
Recruiting |
Allysta Pharmaceutical |
2020-08-31 |
| NCT04181593 |
Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04181593 |
Recruiting |
OmegaD LLC |
2020-07-31 |
| NCT04159935 |
Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04159935 |
Recruiting |
University of Waterloo |
2020-06-30 |
| NCT04144413 |
3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin) |
https://ClinicalTrials.gov/show/NCT04144413 |
Recruiting |
Santen SAS |
2023-05-31 |
| NCT04143841 |
Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04143841 |
Recruiting |
Epitech Mag Ltd. |
2020-10-31 |
| NCT04123626 |
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene |
https://ClinicalTrials.gov/show/NCT04123626 |
Recruiting |
ProQR Therapeutics |
2021-10-07 |
| NCT04120584 |
Clinical Evaluation of Safety and Efficacy of Radio Frequency (Forma Eye) Treatment for Dry Eye Disease Due to Meibomian Gland Dysfunction |
https://ClinicalTrials.gov/show/NCT04120584 |
Recruiting |
InMode MD Ltd. |
2020-10-31 |
| NCT04115800 |
Liposomal Sirolimus in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04115800 |
Recruiting |
Instituto de OftalmologÃa Fundación Conde de Valenciana |
2020-05-01 |
| NCT04105842 |
Refitting Daily Disposable Contact Lens Wearers With Dry Eye Disease With A Different Daily Disposable Lens Type |
https://ClinicalTrials.gov/show/NCT04105842 |
Recruiting |
University of Waterloo |
2020-02-28 |
| NCT04096898 |
Senofilcon A Lenses in Moderate to Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04096898 |
Recruiting |
University of Illinois at Chicago |
2020-12-31 |
| NCT04084483 |
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04084483 |
Completed |
Kowa Research Institute, Inc. |
2020-01-03 |
| NCT04073238 |
Efficacy of Repeated Low-Level Red-Light Therapy in Myopia Control |
https://ClinicalTrials.gov/show/NCT04073238 |
Recruiting |
Zhongshan Ophthalmic Center, Sun Yat-sen University |
2020-12-31 |
| NCT04036292 |
Clinical Trial to Evaluate the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET-2 Study) |
https://ClinicalTrials.gov/show/NCT04036292 |
Active, not recruiting |
Oyster Point Pharma, Inc. |
2020-05-08 |
| NCT04015219 |
Management of Signs and Symptoms Associated With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04015219 |
Recruiting |
Tissue Tech Inc. |
2020-07-01 |
| NCT03992482 |
IVIG-eye Drops Treatment for Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03992482 |
Completed |
University of Illinois at Chicago |
2019-08-02 |
| NCT03990506 |
Photorefractive Intrastromal Crosslinking (PiXL) for the Treatment of Progressive Keratoconus |
https://ClinicalTrials.gov/show/NCT03990506 |
Recruiting |
Umeå University |
2021-06-02 |
| NCT03987880 |
Photorefractive Intrastromal Corneal Crosslinking as a Treatment for Low Grade Myopia |
https://ClinicalTrials.gov/show/NCT03987880 |
Active, not recruiting |
Umeå University |
2020-03-22 |
| NCT03956225 |
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study |
https://ClinicalTrials.gov/show/NCT03956225 |
Active, not recruiting |
Alcon Research |
2020-10-31 |
| NCT03954626 |
Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD |
https://ClinicalTrials.gov/show/NCT03954626 |
Completed |
Novartis |
2019-07-09 |
| NCT03948191 |
99Tc-MDP for Thyroid-Associated Ophthalmopathy |
https://ClinicalTrials.gov/show/NCT03948191 |
Completed |
Dalian University |
2018-12-30 |
| NCT03938545 |
ASCEND GO-2: Study of RVT-1401 for the Treatment of Patients With Active, Moderate to Severe Graves’ Ophthalmopathy ( GO ) |
https://ClinicalTrials.gov/show/NCT03938545 |
Recruiting |
Immunovant Sciences GmbH |
2021-01-31 |
| NCT03922321 |
Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves’ Ophthalmopathy ( GO ) |
https://ClinicalTrials.gov/show/NCT03922321 |
Active, not recruiting |
Immunovant Sciences GmbH |
2020-03-31 |
| NCT03920215 |
Clinical Trial to Evaluate the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET Study) |
https://ClinicalTrials.gov/show/NCT03920215 |
Completed |
Oyster Point Pharma, Inc. |
2019-10-12 |
| NCT03916042 |
A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03916042 |
Active, not recruiting |
Aldeyra Therapeutics, Inc. |
2020-04-30 |
| NCT03913143 |
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) |
https://ClinicalTrials.gov/show/NCT03913143 |
Recruiting |
ProQR Therapeutics |
2020-12-31 |
| NCT03913130 |
Extension Study to Study PQ-110-001 (NCT03140969) |
https://ClinicalTrials.gov/show/NCT03913130 |
Active, not recruiting |
ProQR Therapeutics |
2021-03-31 |
| NCT03907865 |
Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation |
https://ClinicalTrials.gov/show/NCT03907865 |
Completed |
Medical University of Vienna |
2018-11-28 |
| NCT03888183 |
Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03888183 |
Recruiting |
Chang Gung Memorial Hospital |
2020-01-22 |
| NCT03879863 |
The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03879863 |
Active, not recruiting |
Aldeyra Therapeutics, Inc. |
2021-04-30 |
| NCT03873246 |
Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study) |
https://ClinicalTrials.gov/show/NCT03873246 |
Completed |
Oyster Point Pharma, Inc. |
2020-01-07 |
| NCT03872479 |
Single Ascending Dose Study in Participants With LCA10 |
https://ClinicalTrials.gov/show/NCT03872479 |
Recruiting |
Allergan |
2024-03-22 |
| NCT03857919 |
TearCare System to Treat Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03857919 |
Recruiting |
Sight Sciences, Inc. |
2019-10-31 |
| NCT03833882 |
Evaluation of MAF-1217 in Patients With DED |
https://ClinicalTrials.gov/show/NCT03833882 |
Completed |
VISUfarma SpA |
2019-06-19 |
| NCT03827564 |
Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03827564 |
Recruiting |
Allergan |
2020-06-30 |
| NCT03766737 |
Validation of the Utility of an Intelligent Visual Acuity Diagnostic System for Children |
https://ClinicalTrials.gov/show/NCT03766737 |
Completed |
Sun Yat-sen University |
2018-07-20 |
| NCT03766425 |
Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy. |
https://ClinicalTrials.gov/show/NCT03766425 |
Active, not recruiting |
Medical University of Lublin |
2019-07-31 |
| NCT03709641 |
A Study to Evaluate the Safety and Effectiveness of Restylane-Defyne for Punctual Occlusion |
https://ClinicalTrials.gov/show/NCT03709641 |
Completed |
The Eye Care Institute |
2018-11-28 |
| NCT03708627 |
Bimatoprost as a Treatment for Graves’ Orbitopathy |
https://ClinicalTrials.gov/show/NCT03708627 |
Recruiting |
University of Washington |
2021-05-31 |
| NCT03706443 |
Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops |
https://ClinicalTrials.gov/show/NCT03706443 |
Completed |
Ohio State University |
2019-02-28 |
| NCT03691636 |
Eyelash Prostheses Compared to 5.0% Lifitegrast BID for Dry Eye Disease. |
https://ClinicalTrials.gov/show/NCT03691636 |
Recruiting |
D.E.L., LLC |
2019-04-02 |
| NCT03688802 |
Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation (The IMPERIAL Study) |
https://ClinicalTrials.gov/show/NCT03688802 |
Completed |
Oyster Point Pharma, Inc. |
2019-09-30 |
| NCT03667157 |
Liver Function After Intravenous Methylprednisolone Administration |
https://ClinicalTrials.gov/show/NCT03667157 |
Completed |
Medical University of Warsaw |
2016-10-30 |
| NCT03660475 |
Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects |
https://ClinicalTrials.gov/show/NCT03660475 |
Completed |
Total Eye Care, PA |
2018-11-01 |
| NCT03658811 |
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03658811 |
Completed |
Toyos Clinic |
2018-10-30 |
| NCT03652051 |
A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03652051 |
Recruiting |
Azura Ophthalmics |
2020-12-31 |
| NCT03636061 |
Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET-1 Study) |
https://ClinicalTrials.gov/show/NCT03636061 |
Completed |
Oyster Point Pharma, Inc. |
2018-09-26 |
| NCT03633461 |
Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The RAINIER Study) |
https://ClinicalTrials.gov/show/NCT03633461 |
Completed |
Oyster Point Pharma, Inc. |
2018-09-20 |
| NCT03598699 |
A Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03598699 |
Active, not recruiting |
AxeroVision, Inc. |
2019-03-31 |
| NCT03597139 |
Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03597139 |
Completed |
Aurinia Pharmaceuticals Inc. |
2018-11-09 |
| NCT03588624 |
Study of the TearCare System in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03588624 |
Recruiting |
Sight Sciences, Inc. |
2018-09-30 |
| NCT03580343 |
Tofacitinib for Inflammatory Eye Disease |
https://ClinicalTrials.gov/show/NCT03580343 |
Active, not recruiting |
Washington University School of Medicine |
2019-12-01 |
| NCT03527212 |
A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03527212 |
Completed |
Senju Pharmaceutical Co., Ltd. |
2019-03-15 |
| NCT03519815 |
Clinical Study to Evaluate the Efficacy of Ectoin® Containing Eye Spray for Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03519815 |
Completed |
University of Applied Sciences and Arts Northwestern Switzerland |
2018-10-30 |
| NCT03492541 |
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03492541 |
Completed |
Alcon Research |
2019-04-30 |
| NCT03467490 |
Self-care Management Program for Dry Eye Disease Patients Using the heiQ |
https://ClinicalTrials.gov/show/NCT03467490 |
Active, not recruiting |
Lawson Health Research Institute |
2019-01-19 |
| NCT03452397 |
Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study) |
https://ClinicalTrials.gov/show/NCT03452397 |
Completed |
Oyster Point Pharma, Inc. |
2018-05-16 |
| NCT03418727 |
Dry Eye Disease Study With Brimonidine |
https://ClinicalTrials.gov/show/NCT03418727 |
Completed |
Ocugen |
2018-03-29 |
| NCT03415490 |
Self-adherent Wrap Techniques for Orbital Surgery |
https://ClinicalTrials.gov/show/NCT03415490 |
Completed |
Sun Yat-sen University |
2018-04-21 |
| NCT01239069 |
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01239069 |
Completed |
Santen Inc. |
2011-10-31 |
| NCT01235234 |
Trial of CF101 to Treat Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01235234 |
Completed |
Can-Fite BioPharma |
2013-11-30 |
| NCT01135511 |
A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01135511 |
Completed |
Pfizer |
2011-04-30 |
| NCT03871361 |
Abatacept in Patients With Birdshot HLA A29 Uveitis |
https://ClinicalTrials.gov/show/NCT03871361 |
Recruiting |
Universitaire Ziekenhuizen Leuven |
2020-04-01 |
| NCT01024998 |
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) |
https://ClinicalTrials.gov/show/NCT01024998 |
Completed |
Sanofi |
2014-07-31 |
| NCT01016873 |
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD |
https://ClinicalTrials.gov/show/NCT01016873 |
Completed |
Oraya Therapeutics, Inc. |
2012-05-31 |
| NCT01014078 |
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01014078 |
Completed |
Merck Sharp & Dohme Corp. |
2010-03-31 |
| NCT01003691 |
Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy |
https://ClinicalTrials.gov/show/NCT01003691 |
Completed |
Pfizer |
2013-03-31 |
| NCT00957190 |
The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial) |
https://ClinicalTrials.gov/show/NCT00957190 |
Completed |
Maisonneuve-Rosemont Hospital |
2011-09-14 |
| NCT00954057 |
Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED) |
https://ClinicalTrials.gov/show/NCT00954057 |
Completed |
Neothetics, Inc |
2011-06-30 |
| NCT00913029 |
Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG) |
https://ClinicalTrials.gov/show/NCT00913029 |
Completed |
Glaukos Corporation |
2012-09-30 |
| NCT00911924 |
A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT00911924 |
Completed |
Glaukos Corporation |
2013-09-30 |
| NCT00877032 |
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT00877032 |
Completed |
Pfizer |
2011-07-31 |
| NCT03878628 |
Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03878628 |
Recruiting |
Rigshospitalet, Denmark |
2020-04-30 |
| NCT00831662 |
The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637) |
https://ClinicalTrials.gov/show/NCT00831662 |
Completed |
Merck Sharp & Dohme Corp. |
2009-12-31 |
| NCT04150432 |
Correlation Between Exhaled Propofol Concentration With Plasma Concentration in Children |
https://ClinicalTrials.gov/show/NCT04150432 |
Recruiting |
Oslo University Hospital |
2020-06-30 |
| NCT04030962 |
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04030962 |
Recruiting |
Allergan |
2020-09-30 |
| NCT03889886 |
Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03889886 |
Active, not recruiting |
Silk Technologies, Ltd. |
2020-01-31 |
| NCT02003547 |
A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02003547 |
Completed |
Amakem, NV |
2013-12-31 |
| NCT01746563 |
Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01746563 |
Completed |
University of Sao Paulo |
2012-08-31 |
| NCT03846193 |
First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD |
https://ClinicalTrials.gov/show/NCT03846193 |
Recruiting |
Gyroscope Therapeutics |
2021-06-30 |
| NCT04139122 |
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04139122 |
Completed |
Senju Pharmaceutical Co., Ltd. |
2020-03-03 |
| NCT04005651 |
Safety and Efficacy of a Trifocal Intraocular Lens (IOL) POD L GF in Comparison With a Multifocal and a Monofocal IOL |
https://ClinicalTrials.gov/show/NCT04005651 |
Recruiting |
Physiol |
2020-06-30 |
| NCT03451396 |
Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms |
https://ClinicalTrials.gov/show/NCT03451396 |
Completed |
Lifelong Vision Foundation |
2018-02-01 |
| NCT03089580 |
Intense Pulsed Light Study for Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03089580 |
Completed |
University of Michigan |
2018-11-01 |
| NCT02766660 |
Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated Ophthalmopathy |
https://ClinicalTrials.gov/show/NCT02766660 |
Completed |
Neon Hospital |
2013-01-31 |
| NCT02579837 |
CLEAR SIGHT: A Trial of Non-Mydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease |
https://ClinicalTrials.gov/show/NCT02579837 |
Active, not recruiting |
Western University, Canada |
2020-07-31 |
| NCT03461211 |
Treatment of Graves’ Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study |
https://ClinicalTrials.gov/show/NCT03461211 |
Active, not recruiting |
Horizon Pharma USA, Inc. |
2020-06-08 |
| NCT04096612 |
The Therapeutic Effect of Dysthyroid Optic Neuropathy |
https://ClinicalTrials.gov/show/NCT04096612 |
Recruiting |
Sun Yat-sen University |
2018-12-31 |
| NCT03855462 |
Evaluating Medium-chain Triglycerides as a Temporary Intraocular Tamponading Agent for Retinal Detachment |
https://ClinicalTrials.gov/show/NCT03855462 |
Recruiting |
University Hospital, Toulouse |
2019-09-30 |
| NCT03780257 |
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene |
https://ClinicalTrials.gov/show/NCT03780257 |
Recruiting |
ProQR Therapeutics |
2021-12-31 |
| NCT00760045 |
Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time |
https://ClinicalTrials.gov/show/NCT00760045 |
Completed |
Alcon Research |
2008-10-31 |
| NCT00758784 |
Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00758784 |
Completed |
Bausch & Lomb Incorporated |
2009-06-30 |
| NCT00680108 |
A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution |
https://ClinicalTrials.gov/show/NCT00680108 |
Completed |
Merck Sharp & Dohme Corp. |
2000-05-31 |
| NCT00679718 |
A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00679718 |
Completed |
Merck Sharp & Dohme Corp. |
2000-07-31 |
| NCT00667004 |
Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00667004 |
Completed |
Bausch & Lomb Incorporated |
2008-12-31 |
| NCT00610480 |
Effects of Tear Film Stability After Instillation Of OTC Artificial Drops |
https://ClinicalTrials.gov/show/NCT00610480 |
Completed |
University of Texas Southwestern Medical Center |
2009-03-31 |
| NCT00600288 |
Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634) |
https://ClinicalTrials.gov/show/NCT00600288 |
Completed |
Merck Sharp & Dohme Corp. |
2008-05-31 |
| NCT00599716 |
Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00599716 |
Completed |
Lantibio |
2008-04-30 |
| NCT00595335 |
Trial of Rituximab for Graves’ Ophthalmopathy |
https://ClinicalTrials.gov/show/NCT00595335 |
Completed |
Mayo Clinic |
2013-03-31 |
| NCT00591110 |
Project inCharge: Increasing the Rate of Comprehensive Eye Care Utilization by Older African Americans Through Community-Based Eye Health Education Program |
https://ClinicalTrials.gov/show/NCT00591110 |
Completed |
University of Alabama at Birmingham |
2009-03-31 |
| NCT00567177 |
Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00567177 |
Completed |
Innovative Medical |
NA |
| NCT00520260 |
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase |
https://ClinicalTrials.gov/show/NCT00520260 |
Completed |
Florida Eye Microsurgical Institute |
2008-08-31 |
| NCT00430547 |
Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies |
https://ClinicalTrials.gov/show/NCT00430547 |
Completed |
Barwon Health |
NA |
| NCT00424151 |
Rituximab Treatment of Graves’ Dysthyroid Ophthalmopathy |
https://ClinicalTrials.gov/show/NCT00424151 |
Completed |
Silkiss, Rona Z., M.D., FACS |
2009-03-31 |
| NCT00799682 |
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® |
https://ClinicalTrials.gov/show/NCT00799682 |
Completed |
Ophthalmic Consultants of Long Island |
2011-01-31 |
| NCT00407043 |
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis |
https://ClinicalTrials.gov/show/NCT00407043 |
Completed |
Ophthalmic Consultants of Long Island |
2007-09-30 |
| NCT00404131 |
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00404131 |
Completed |
Merck Sharp & Dohme Corp. |
2001-12-31 |
| NCT00403975 |
Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00403975 |
Completed |
Merck Sharp & Dohme Corp. |
2004-11-30 |
| NCT00403715 |
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00403715 |
Completed |
Merck Sharp & Dohme Corp. |
2002-09-30 |
| NCT00395759 |
The Visual Effect of an Investigational Artificial Tear in the Tear Layer. |
https://ClinicalTrials.gov/show/NCT00395759 |
Completed |
Southern California College of Optometry |
NA |
| NCT00386906 |
Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma |
https://ClinicalTrials.gov/show/NCT00386906 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-05-31 |
| NCT00348413 |
Thyroid Treatment Trial |
https://ClinicalTrials.gov/show/NCT00348413 |
Completed |
Singapore National Eye Centre |
2008-07-31 |
| NCT00345176 |
Age-Related Eye Disease Study 2 (AREDS2) |
https://ClinicalTrials.gov/show/NCT00345176 |
Completed |
National Eye Institute (NEI) |
2012-10-31 |
| NCT00337298 |
The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT00337298 |
Completed |
University of Aarhus |
2009-02-28 |
| NCT00333203 |
Next Generation Ophthalmic Irrigating Solution Posterior Segment Study |
https://ClinicalTrials.gov/show/NCT00333203 |
Completed |
Alcon Research |
2006-03-31 |
| NCT00315640 |
Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation |
https://ClinicalTrials.gov/show/NCT00315640 |
Completed |
Alcon Research |
2009-07-31 |
| NCT00270647 |
Physicians’ Health Study II |
https://ClinicalTrials.gov/show/NCT00270647 |
Completed |
Brigham and Women’s Hospital |
2011-06-30 |
| NCT00211432 |
Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg) |
https://ClinicalTrials.gov/show/NCT00211432 |
Completed |
Manhattan Eye, Ear & Throat Hospital |
2010-04-30 |
| NCT00150111 |
Rituximab in the Treatment of Graves’ Disease |
https://ClinicalTrials.gov/show/NCT00150111 |
Completed |
Odense University Hospital |
NA |
| NCT00123279 |
Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy |
https://ClinicalTrials.gov/show/NCT00123279 |
Completed |
ThromboGenics |
2007-02-28 |
| NCT00120432 |
Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation |
https://ClinicalTrials.gov/show/NCT00120432 |
Completed |
Khon Kaen University |
NA |
| NCT00006422 |
Evaluation and Treatment of Pediatric Eye Diseases |
https://ClinicalTrials.gov/show/NCT00006422 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00004660 |
Randomized Study of Sequential Orbital Radiotherapy for Graves’ Ophthalmopathy |
https://ClinicalTrials.gov/show/NCT00004660 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
1998-01-31 |
| NCT00001737 |
Cyclosporin Implant to Treat Uveitis |
https://ClinicalTrials.gov/show/NCT00001737 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00000145 |
Age-Related Eye Disease Study (AREDS) |
https://ClinicalTrials.gov/show/NCT00000145 |
Completed |
National Eye Institute (NEI) |
2001-10-31 |